21 – 30 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The metabolomic profile associated with clustering of cardiovascular risk factors A multi-sample evaluation
(
- Contribution to journal › Article
-
Mark
Metabolic Profiling of Obesity With and Without the Metabolic Syndrome : A Multisample Evaluation
(
- Contribution to journal › Article
-
Mark
The value of combining individual and small area sociodemographic data for assessing and handling selective participation in cohort studies : Evidence from the Swedish CardioPulmonary bioImage Study
(
- Contribution to journal › Article
-
Mark
Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors : Results From the SWEDEHEART Registry
(
- Contribution to journal › Article
-
Mark
An online atlas of human plasma metabolite signatures of gut microbiome composition
(
- Contribution to journal › Article
-
Mark
Accelerometer derived physical activity patterns in 27.890 middle-aged adults : The SCAPIS cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Bronchodilator response in FOT parameters in middle-aged adults from SCAPIS : Normal values and relationship to asthma and wheezing
(
- Contribution to journal › Letter
-
Mark
Blood pressure phenotypes based on ambulatory monitoring in a general middle-aged population
(
- Contribution to journal › Article
-
Mark
Mortality in STEMI patients without standard modifiable risk factors : a sex-disaggregated analysis of SWEDEHEART registry data
(
- Contribution to journal › Article
-
Mark
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
(
- Contribution to journal › Article